Statistical methods in medical research
-
Stat Methods Med Res · Apr 2018
Semiparametric models for multilevel overdispersed count data with extra zeros.
This study proposes semiparametric models for analysis of hierarchical count data containing excess zeros and overdispersion simultaneously. The methods discussed in this paper handle nonlinear covariate effects through flexible semiparametric multilevel regression techniques. ⋯ The performance of the proposed models is assessed by using a Monte Carlo simulation study. We also illustrated the methods by the analysis of decayed, missing, and filled teeth of children aged 5-14 years old.
-
Stat Methods Med Res · Feb 2018
Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization.
Conventionally, phase I dose-finding trials aim to determine the maximum tolerated dose of a new drug under the assumption that both toxicity and efficacy monotonically increase with the dose. This paradigm, however, is not suitable for some molecularly targeted agents, such as monoclonal antibodies, for which efficacy often increases initially with the dose and then plateaus. For molecularly targeted agents, the goal is to find the optimal dose, defined as the lowest safe dose that achieves the highest efficacy. ⋯ The simulation studies show that the proposed design has good operating characteristics. This method is going to be applied in more than two phase I clinical trials as no other method is available for this specific setting. We also provide an R package dfmta that can be downloaded from CRAN website.
-
Stat Methods Med Res · Apr 2017
On the analysis of composite measures of quality in medical research.
Composite endpoints are commonplace in biomedical research. The complex nature of many health conditions and medical interventions demand that composite endpoints be employed. Different approaches exist for the analysis of composite endpoints. ⋯ Considering the BETTER trial data, the distinct effect GEE model struggled with convergence and the collapsed composite method estimated an effect, which was greatly attenuated compared to other models. All remaining models suggested an intervention effect of similar magnitude. In our simulation study, the binomial logistic regression model (corrected for possible over/under-dispersion), the linear regression model, the Poisson regression model (corrected for over-dispersion) and the common effect logistic GEE model appeared to be unbiased, with good type 1 error rates, power and convergence properties.
-
Stat Methods Med Res · Feb 2017
Statistical methods for incomplete data: Some results on model misspecification.
Inverse probability weighted estimating equations and multiple imputation are two of the most studied frameworks for dealing with incomplete data in clinical and epidemiological research. We examine the limiting behaviour of estimators arising from inverse probability weighted estimating equations, augmented inverse probability weighted estimating equations and multiple imputation when the requisite auxiliary models are misspecified. ⋯ We further demonstrate that use of inverse probability weighting or multiple imputation with slightly misspecified auxiliary models can actually result in greater asymptotic bias than the use of naïve, complete case analyses. These asymptotic results are shown to be consistent with empirical results from simulation studies.
-
Stat Methods Med Res · Feb 2017
Tests for equivalence of two survival functions: Alternative to the tests under proportional hazards.
For either the equivalence trial or the non-inferiority trial with survivor outcomes from two treatment groups, the most popular testing procedure is the extension (e.g., Wellek, A log-rank test for equivalence of two survivor functions, Biometrics, 1993; 49: 877-881) of log-rank based test under proportional hazards model. We show that the actual type I error rate for the popular procedure of Wellek is higher than the intended nominal rate when survival responses from two treatment arms satisfy the proportional odds survival model. ⋯ We further show that our new equivalence test, formulation, and related procedures are applicable even in the presence of additional covariates beyond treatment arms, and the associated equivalence test procedures have correct type I error rates under the proportional hazards model as well as the proportional odds survival model. These results show that use of our test will be a safer statistical practice for equivalence trials of survival responses than the commonly used log-rank based tests.